ChemT Biotechnology
Singapore, SG · 4 known investors
ChemT builds CelMo, an AI-driven virtual cell platform that models cell states and predicts responses to process, genetic, and molecular changes to optimize biomanufacturing. It applies this to CHO cells for antibody/protein production and T cell therapy manufacturing (including its Chemplify small molecule), serving biopharma teams working on cell line and process development.
Founders & leadership
Investors · 4
Funding
SEC filings, press & company announcements$9M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ChemT Biotechnology do?
- ChemT builds CelMo, an AI-driven virtual cell platform that models cell states and predicts responses to process, genetic, and molecular changes to optimize biomanufacturing. It applies this to CHO cells for antibody/protein production and T cell therapy manufacturing (including its Chemplify small molecule), serving biopharma teams working on cell line and process development.
- Who founded ChemT Biotechnology?
- ChemT Biotechnology was founded by Ling Wu, Jie Sun.
- Who are ChemT Biotechnology's investors?
- ChemT Biotechnology's investors include Draper University Ventures, ACADEMY INVESTOR, AIN Ventures, Wavemaker Partners.
- How much funding has ChemT Biotechnology raised?
- ChemT Biotechnology has disclosed $9M raised across 2 rounds.
- Where is ChemT Biotechnology headquartered?
- ChemT Biotechnology is headquartered in Singapore, SG.